We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AUPH Aurinia Pharmaceuticals Inc

0.09 (1.03%)
Dec 08 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,251,742
Bid Price 8.80
Ask Price 8.86
News -
Day High 8.885


52 Week Range


Day Low 8.70
Share Name Share Symbol Market Stock Type
Aurinia Pharmaceuticals Inc AUPH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.09 1.03% 8.86 19:00:00
Open Price Low Price High Price Close Price Previous Close
8.85 8.70 8.885 8.86 8.77
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
11,466 1,251,742 US$ 8.79 US$ 11,008,732 - 4.07 - 12.43
Last Trade Type Quantity Price Currency
18:59:59 formt 200 US$ 8.86 USD

Aurinia Pharmaceuticals (AUPH) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Aurinia Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.27B 143.61M - 135.55M -108.18M -0.75 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Aurinia Pharmaceuticals News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No AUPH Message Board. Create One! See More Posts on AUPH Message Board See More Message Board Posts

Historical AUPH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week8.599.1258.428.881,787,4650.273.14%
1 Month7.6010.057.508.722,176,1091.2616.58%
3 Months9.0810.056.94018.101,965,620-0.22-2.42%
6 Months10.5112.436.94019.232,029,102-1.65-15.7%
1 Year4.6512.434.079.092,512,5374.2190.54%
3 Years15.1333.97154.0713.323,159,791-6.27-41.44%
5 Years6.1533.97153.5213.232,422,9112.7144.07%

Aurinia Pharmaceuticals Description

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |